The non-specific effects of vaccines

Archives of Disease in Childhood

Volumn 95, Issue 9, 2010, Pages 662-667

  Shann, Frank ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; IRON; MEASLES VACCINE; RETINOL; ZINC; VACCINE;

CHILDHOOD MORTALITY; CLINICAL TRIAL; CROSS REACTION; DIPHTHERIA; DRUG EFFECT; DRUG EFFICACY; EPIDEMIC; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; INFECTION PREVENTION; INNATE IMMUNITY; MEASLES; NEISSERIA MENINGITIDIS; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SEX DIFFERENCE; SEX RATIO; T LYMPHOCYTE; TETANUS; TUBERCULOSIS; VACCINATION; ANIMAL; COMMUNICABLE DISEASE; DISEASE MODEL; FEMALE; IMMUNOLOGY; INFANT; MALE; MORTALITY;

ANIMALS; BCG VACCINE; COMMUNICABLE DISEASES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT; MALE; MEASLES VACCINE; VACCINES;

EID: 77955733284     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.157537     Document Type: Review

References (58)

1. Clark IA. Heterologous immunity revisited. Parasitology 2001;122(Suppl):S51-9.
2. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002;2:417-26.
3. Rehermann B, Shin EC. Private aspects of heterologous immunity. J Exp Med 2005;201:667-70.
4. Selin LK, Brehm MA, Naumov YN, et al. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 2006;211:164-81.
5. Welsh RM, Fujinami RS. Pathogenic epitopes, heterologous immunity and vaccine design. Nat Rev Microbiol 2007;5:555-63.
6. Didierlaurent A, Goulding J, Hussell T. The impact of successive infections on the lung microenvironment. Immunology 2007;122:457-65. (Pubitemid 350075963)
7. Shann F. Heterologous immunity and the nonspecific effects of vaccines: a major medical advance? Pediatr Infect Dis J 2004;23:555-8. (Pubitemid 38802303)
8. Cutts FT. Advances and challenges for the expanded programme on immunization. Br Med Bull 1998;54:445-61.
9. Fine PE, Smith PG. 'Non-specific effects of vaccines' - an important analytical insight, and call for a workshop. Trop Med Int Health 2007;12:1-4.
10. Jensen H, Benn CS, Lisse IM, et al. Survival bias in observational studies of the impact of routine immunizations on childhood survival. Trop Med Int Health 2007;12:5-14. (Pubitemid 44973849)
11. Aaby P, Benn CS, Nielsen J, et al. DTP vaccination and child survival in observational studies with incomplete vaccination data. Trop Med Int Health 2007;12:15-24. (Pubitemid 44973850)
12. Newell KW, Dueñas Lehmann A, LeBlanc DR, et al. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. Bull World Health Organ 1966;35:863-71.
13. Riley ID, Tarr PI, Andrews M, et al. Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet 1977;1:1338-41. (Pubitemid 8127683)
14. Black RE, Huber DH, Curlin GT. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bull World Health Organ 1980;58:927-30.
15. Riley ID, Lehmann D, Alpers MP, et al. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children. Lancet 1986;2:877-81. (Pubitemid 17170640)
16. Cutts FT, Zaman SM, Enwere G, et al.; Gambian Pneumococcal Vaccine Trial Group. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, doubleblind, placebo-controlled trial. Lancet 2005;365:1139-46. (Pubitemid 40417563)
17. Roth A, Garly ML, Jensen H, et al. Bacillus Calmette-Guérin vaccination and infant mortality. Expert Rev Vaccines 2006;5:277-93. (Pubitemid 44179957)
18. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002;94:167-73.
19. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996;125:605-13.
20. Crowcroft NS, Stein C, Duclos P, et al. How best to estimate the global burden of pertussis? Lancet Infect Dis 2003;3:413-18. (Pubitemid 36791118)
21. Clark IA, Allison AC, Cox FE. Protection of mice against Babesia and Plasmodium with BCG. Nature 1976;259:309-11.
22. Guy B. The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 2007;5:505-17. (Pubitemid 46925379)
23. Benn CS, Diness BR, Roth A, et al. Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial. BMJ 2008;336:1416-20. (Pubitemid 351946981)
24. Benn CS, Lund S, Fisker A, et al. Should infant girls receive micronutrient supplements? Int J Epidemiol 2009;38:586-90.
25. Aaby P, Samb B, Simondon F, et al. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995;311:481-5.
26. Aaby P, Garly ML, Nielsen J, et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J 2007;26:247-52. (Pubitemid 46340773)
27. Aaby P, Jensen H, Samb B, et al. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003;361:2183-8.
28. Aaby P, Samb B, Simondon F, et al. Sex-specific differences in mortality after high-titre measles immunization in rural Senegal. Bull World Health Organ 1994;72:761-70. (Pubitemid 24344101)
29. Aaby P, Ibrahim SA, Libman MD, et al. The sequence of vaccinations and increased female mortality after high-titre measles vaccine: trials from rural Sudan and Kinshasa. Vaccine 2006;24:2764-71.
30. Aaby P, Jensen H, Garly ML, et al. Routine vaccinations and child survival in a war situation with high mortality: effect of gender. Vaccine 2002;21:15-20. (Pubitemid 35351347)
31. Aaby P, Jensen H, Gomes J, et al. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol 2004;33:374-80. (Pubitemid 38578839)
32. Veirum JE, Sodemann M, Biai S, et al. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2005;23:1197-204. (Pubitemid 40052016)
33. Aaby P, Vessari H, Nielsen J, et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J 2006;25:721-7. (Pubitemid 44162130)
34. Aaby P, Rodrigues A, Biai S, et al. Oral polio vaccination and low case fatality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 2004;22:3014-17. (Pubitemid 39037202)
35. Aaby P, Jensen H, Rodrigues A, et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. Int J Epidemiol 2004;33:367-73. (Pubitemid 38578838)
36. Garly ML, Trautner SL, Marx C, et al. Thymus size at 6 months of age and subsequent child mortality. J Pediatr 2008;153:683-8, 688.e1-3.
37. Rook GA, Brunet LR. Give us this day our daily germs. Biologist (London) 2002;49:145-9.
38. Fine PE, Williams TN, Aaby P, et al.; Working Group on Non-specific Effects of Vaccines. Epidemiological studies of the 'non-specific effects' of vaccines: I - data collection in observational studies. Trop Med Int Health 2009;14:969-76.
39. Farrington CP, Firth MJ, Moulton LH, et al.; Working Group on Non-specific Effects of Vaccines. Epidemiological studies of the non-specific effects of vaccines: II - methodological issues in the design and analysis of cohort studies. Trop Med Int Health 2009;14:977-85.
40. Shann F, Nohynek H, Scott JA, et al. Randomized trials to study the non-specific effects of vaccines in children in low-income countries. Pediatr Infect Dis J (In Press).
41. Chen HD, Fraire AE, Joris I, et al. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am J Pathol 2003;163:1341-55. (Pubitemid 37175083)
42. Aaby P, Bukh J, Lisse IM, et al. Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau. J Infect 1984;8:13-21. (Pubitemid 14223302)
43. Aaby P, Andersen M, Sodemann M, et al. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age. BMJ 1993;307:1308-11. (Pubitemid 23337746)
44. Mathurin KS, Martens GW, Kornfeld H, et al. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol 2009;83:3528-39.
45. Rosenthal, Loewinsohn E, Graham ML, et al. BCG vaccination in tuberculous households. Am Rev Respir Dis 1961;84:690-704.
46. Ferguson RG, Simes AB. BCG vaccination of Indian infants in Saskatchewan. Tubercle 1949;30:5-11.
47. Aronson JD. Protective vaccination against tuberculosis with special reference to BCG vaccination. Am Rev Tuberc 1948;58:255-81.
48. Medical Research Council. B.C.G. and vole bacillus vaccines in the prevention of tuberculosis in adolescents. Br Med J 1959;2:379-96.
49. Levine M, Sackett MF. Results of BCG immunization in New York City. Am Rev Tuberc 1948;53:517-32.
50. Kristensen I, Aaby P, Jensen H. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 2000;321:1435-8.
51. Vaugelade J, Pinchinat S, Guiella G, et al. Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. BMJ 2004;329:1309. (Pubitemid 40754254)
52. Chan GJ, Moulton LH, Becker S, et al. Non-specific effects of diphtheria tetanus pertussis vaccination on child mortality in Cebu, The Philippines. Int J Epidemiol 2007;36:1022-9. (Pubitemid 350018546)
53. Velema JP, Alihonou EM, Gandaho T, et al. Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol 1991;20:474-9.
54. Benn CS, Aaby P, Nielsen J, et al. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana Vitamin A Supplementation Trial. Am J Clin Nutr 2009;90:629-39.
55. Benn CS, Rodrigues A, Yazdanbakhsh M, et al. The effect of high-dose vitamin A supplementation administered with BCG vaccine at birth may be modified by subsequent DTP vaccination. Vaccine 2009;27:2891-8.
56. Prentice AM, Savy M, Darboe MK, et al. Commentary: challenging public health orthodoxies - prophesy or heresy? Int J Epidemiol 2009;38:591-3.
57. World Health Organization. Meeting of Global Advisory Committee on Vaccine Safety, 18-19 June 2008. Wkly Epidemiol Rec 2008;83:287-92.
58. Low PP, Rutherfurd KJ, Gill HS, et al. Effect of dietary whey protein concentrate on primary and secondary antibody responses in immunized BALB/c mice. Int Immunopharmacol 2003;3:393-401.